Innovative Prosthetic Systems for Pediatric Limb Loss to Accommodate Growth

Description

An immediate fit adjustable prosthetic system is being investigated for children. The age range being recruited is from 3 years up to 18 years old. Phase I of this study will involve developing a final prototype by conducting in-lab testing on children with limb loss. Phase II will involve a two month home trial to further evaluate the comfort and usability of the socket. Outcome measures include a PEQ-based questionnaire, socket pressure measures and gait analysis.

Conditions

Limb Deficiencies, Pediatric ALL

Study Overview

Study Details

Study overview

An immediate fit adjustable prosthetic system is being investigated for children. The age range being recruited is from 3 years up to 18 years old. Phase I of this study will involve developing a final prototype by conducting in-lab testing on children with limb loss. Phase II will involve a two month home trial to further evaluate the comfort and usability of the socket. Outcome measures include a PEQ-based questionnaire, socket pressure measures and gait analysis.

Innovative Prosthetic Systems for Pediatric Limb Loss to Accommodate Growth

Innovative Prosthetic Systems for Pediatric Limb Loss to Accommodate Growth

Condition
Limb Deficiencies
Intervention / Treatment

-

Contacts and Locations

Philadelphia

Penn Medicine Rittenhouse, Philadelphia, Pennsylvania, United States, 19146

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Four months post-amputation
  • * Subjects who have lost a limb due to any cause: trauma, congenital limb loss, dysvascular causes (peripheral vascular disease and diabetes), or malignancy will all be eligible for inclusion.
  • * Intact, protective sensation in their residual limbs.
  • * open skin lesions
  • * excessive pain in the residual limb (phantom pain, residual limb pain, or neuroma)
  • * neurological disorders (e.g., stroke, severe polyneuropathy) causing weakness in the contralateral leg or marked gait impairment
  • * inability to follow instructions for trial

Ages Eligible for Study

3 Years to 18 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Pennsylvania,

Timothy R Dillingham, MS,MD, PRINCIPAL_INVESTIGATOR, University of Pennsylvania

Study Record Dates

2025-08-31